Back to search results
NCT07037030

Mindfulness ADHD Intervention

Enrolling by Invitation
NAAges 7–11InterventionalTreatment
Boston Children's Hospital
~10 participants
Updated 2026-03-31 on ClinicalTrials.gov
What's tested:Guided deep breathing

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Behavioral Performance Metrics
Measured over During the single in-person research visit
+1 more outcome measured

Conditions

Attention Deficit Hyperactivity Disorder (ADHD)

Explore related trials

Attention Deficit Hyperactivity Disorder

Where it's being run

1 sites across 1 states
Massachusetts1

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Participant age 7 years, 0 months - 11 years, 11 months
Parent-reported ADHD diagnosis for the participant

Exclusion

Previous confirmed or suspected diagnosis of intellectual disability
Previous confirmed or suspected diagnosis of autism spectrum disorder
Currently prescribed non-stimulant medication for the purpose of managing ADHD symptoms
Hearing impairments
Primary language other than English
Known seizure disorder

What this trial measures

  • Behavioral Performance MetricsDuring the single in-person research visit

    Behavioral markers of sustained attention and inhibitory control will be assessed using a Go/NoGo task. Omission errors (failing to respond to a Go trial) and reaction time variability (standard deviation of reaction time across all trials) will serve as markers of sustained attention. Commission errors (responding to a NoGo trial) will serve as a marker of inhibitory control.

  • Neurophysiological MarkersDuring the single in-person research visit

    Electroencephalography (EEG) methods will be used to measure P300 event-related potentials (ERP), a positive inflection occurring around 300ms after a response to task-relevant and irrelevant stimuli that reflects attention orienting, stimulus evaluation, and inhibitory control. Stimulus-locked P300 amplitude in response to correct Go-trials will be a marker of cortical attention processes, while stimulus-locked P300 amplitude in response to NoGo trials will be a marker of cortical inhibitory control processes.